Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
PLoS Pathog. 2018 Nov 1;14(11):e1007222. doi: 10.1371/journal.ppat.1007222. eCollection 2018 Nov.
In this brief review and perspective, we address the question of whether the immune responses that bring about immune control of acute HIV infection are the same as, or distinct from, those that maintain long-term viral suppression once control of viremia has been achieved. To this end, we describe the natural history of elite and post-treatment control, noting the lack of data regarding what happens acutely. We review the evidence suggesting that the two clinical phenotypes may differ in terms of the mechanisms required to achieve and maintain control, as well as the level of inflammation that persists once a steady state is achieved. We then describe the evidence from longitudinal studies of controllers who fail and studies of biologic sex (male versus female), age (children versus adults), and simian immunodeficiency virus (SIV) (pathogenic/experimental versus nonpathogenic/natural infection). Collectively, these studies demonstrate that the battle between the inflammatory and anti-inflammatory pathways during acute infection has long-term consequences, both for the degree to which control is maintained and the health of the individual. Potent and stringent control of HIV may be required acutely, but once control is established, the chronic inflammatory response can be detrimental. Interventional approaches designed to bring about HIV cure and/or remission should be nuanced accordingly.
在这篇简短的综述和观点中,我们探讨了一个问题,即急性 HIV 感染时实现免疫控制的免疫反应是否与一旦控制了病毒血症就维持长期病毒抑制的反应相同或不同。为此,我们描述了精英和治疗后控制的自然史,指出在急性阶段缺乏相关数据。我们回顾了一些证据,这些证据表明,两种临床表型在实现和维持控制所需的机制以及达到稳定状态后持续存在的炎症水平方面可能存在差异。然后,我们描述了对未能控制病毒的控制器的纵向研究以及对生物学性别(男性与女性)、年龄(儿童与成人)和猴免疫缺陷病毒(SIV)(致病性/实验性与非致病性/自然感染)的研究证据。这些研究表明,急性感染期间炎症和抗炎途径之间的斗争具有长期后果,既影响控制的程度,也影响个体的健康。在急性阶段可能需要强烈而严格地控制 HIV,但一旦控制建立,慢性炎症反应可能有害。旨在实现 HIV 治愈和/或缓解的干预方法应根据需要进行调整。